{
    "patient": {
        "Name": "Gloria Potter",
        "DateOfBirth": "1998-09-08",
        "Sex": "Male",
        "Diagnosis": "Lymphoma",
        "BodyPart": "Colorectal",
        "Physician": "Dr. Laurie Clark",
        "TreatingInstitution": "Soto-Norris"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Colorectal",
            "CollectedDate": "2023-09-09",
            "ReceivedDate": "2023-09-09",
            "TumorPercentage": "51%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-09-14",
            "ReceivedDate": "2023-09-14"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "TEK",
                "DNA Alteration": "c.1354A>G",
                "GeneMutation": "p.N452D Frameshift-GOF",
                "VariantAlleleFraction": "31.81%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "IKZF1",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.N159Y Frameshift-LOF",
                "VariantAlleleFraction": "33.51%"
            },
            {
                "Gene": "IDH2",
                "DNA Alteration": "c.419G>A",
                "GeneMutation": "p.R172W Spliceregionvariant-LOF",
                "VariantAlleleFraction": "16.96%"
            },
            {
                "Gene": "ALK",
                "DNA Alteration": "c.3512_3513delinsAT",
                "GeneMutation": "p.R172S Spliceregionvariant-LOF",
                "VariantAlleleFraction": "22.44%"
            },
            {
                "Gene": "MYO1G",
                "DNA Alteration": "c.145G>A",
                "GeneMutation": "p.T1087I Spliceregionvariant-LOF",
                "VariantAlleleFraction": "13.92%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": [
            "KRAS",
            "HDAC2",
            "MET",
            "B2M"
        ]
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "45 m/Mb",
            "Tmbpercentile": "67%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Equivocal"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}